Gastroenterology & Hepatology Research
Torres profile photo

Innovative Research

Our physician scientists and clinical investigators are leading the way in enhancing the prevention, diagnosis, and treatment of gastrointestinal and hepatology diseases through their research.
Our Research

The U-M Medical School Department of Internal Medicine Division of Gastroenterology and Hepatology has a long tradition of excellence and national leadership in basic science and clinical research and is consistently among the top divisions funded by the National Institutes of Health.

Continuing in this tradition, our division conducts cutting-edge investigations into the molecular, cellular, and physiological conditions of normal and disease states of the gastrointestinal tract, liver, and pancreas, and state-of-the-art clinical research ranging from hepatitis C to Wilson Disease. 

Advanced training and collaborative research involving faculty, fellows, medical students, and graduate students enhance our research endeavors to discover cures and improve clinical outcomes.
Clinical & Research Programs

The Division of Gastroenterology and Hepatology is home to multiple nationally-recognized clinical and research programs.

Learn More About Our Programs
GI & Hepatology Research

Learn more about the Division of Gastroenterology and Hepatology research.

Get to know our faculty and their research

Gut Talk, on Healio Gastroenterology, is a podcast hosted by Dr. Sameer Berry and Dr. William Chey that explores the impact of health policy, technology, practice management, and research on the field of gastroenterology. Listen to the podcast.
T32 Training Programs

Our three-year GI Fellowship Training Program prepares fellows for careers in academic medicine and is separated into three tracks, including two NIH-funded tracks:

  1. NIH-funded T32 Clinical Research track (“Gastroenterology/Research-Outcomes” – NRMP Program Code 1293144F2)
  2. NIH-funded T32 Basic/Translational Research track (“Gastroenterology/Basic Science Research” – NRMP Program Code 1293144F1)

Learn more about the GI fellowship
Featured News & Stories See all news Dr. Akbar K. Waljee
Department News
Akbar K. Waljee, MD Appointed as New Executive Director of Center for Global Health Equity
Lyle C. Roll Professor and Assistant Dean for Global Health Research, Akbar K. Waljee, MD, from the Departments of Learning Health Sciences, Internal Medicine, and Epidemiology, has been newly appointed as the Leslie D. Yamada and Tachi Yamada MD Executive Director of The Center for Global Health Equity at the University of Michigan.
 a hand on a table with a prick of blood on finger
Health Lab
Simple blood test for IBS-triggering foods shows promise in study
A multicenter study compared patients with irritable bowel syndrome on Immunoglobulin G-based elimination diets to patients on sham diets. 
 shot in arm patient rolled up sleeve
Health Lab
Why anti-TNF drugs don’t work for some kids with Crohn's disease
Research from Michigan Medicine investigated possible genetic factors for drug efficacy for children with Crohn’s disease. 
 Elliot Tapper
Department News
Internal Medicine Faculty Spotlight − Dr. Elliot Tapper
Elliott Tapper, MD, FASSLD is an Associate Professor of Internal Medicine and Academic Chief of Hepatology in the Division of Gastroenterology and Hepatology.
 Dr. Stidham in AGA News
Department News
How AI can help physicians: Dr. Stidham's interview in the American Gastroenterological Association News
Dr. Stidham's interview in AGA "GI Docs will need to forge a 'Human-Computer Cooperative'"
 syringes three in a row with one with a shot going into it on a light teal background
Health Lab
TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies
Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data.